A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trial

- Lamb, David S., Denham, James W., D'Este, Catherine, Joseph, David, Matthews, John, Atkinson, Chris, Spry, Nigel A., Duchesne, Gillian, Ebert, Martin, Steigler, Allison, Delahunt, Brett

A methodology for the analysis of PSA response signatures

- Ebert, Martin A., Lamb, David S., Joseph, David J., Steigler, Allison, Denham, James W.

A randomised trial investigating the effect on biochemical (PSA) control and survival of different durations of adjuvant androgen deprivation in association with definitive radiation treatment for localised carcinoma of the prostate

- Lamb, David, Joesph, David, Turner, Sandra, Diamond, Terry, Steigler, Allison, Attia, John, Delahunt, Brett, Haworth, Annette, Denham, Jim, Duchesne, Gillian, Atkinson, Chris, Kenny, Lizbeth, Gogna, Kumar, Matthews, John, Spry, Nigel, Tai, Keen-Hun

Androgen deprivation therapy for prostate cancer does not increase cardiovascular mortality in the long term

- Wilcox, Chantelle, Kautto, Allison, Steigler, Allison, Denham, James W.

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis

- Kishan, Amar U., Sun, Yilun, Armstrong, John G., Nabid, Abdenour, Carrier, Nahtalie, Souhami, Luis, Dunne, Mary T., Efstathiou, Jason A., Sandler, Howard M., Guerrero, Araceli, Joseph, David, Maingon, Philippe, Hartman, Holly, de Reijke, Theo M., Maldonado, X, Ma, TM, Romero, T, Wang, X, Rettig, MB, Reiter, RE, Zaorsky, NG, Steinberg, ML, Nickols, NG, Pisansky, Thomas M., Jia, AY, Garcia, JA, Spratt, DE, Bolla, Michel, Neven, Anouk, Steigler, Allison, Denham, James W., Feng, Felix Y., Zapatero, Almudena

Association between measures of treatment quality and disease progression in prostate cancer radiotherapy: An exploratory analysis from the TROG 03.04 RADAR trial

- Marcello, Marco, Ebert, Martin A., Haworth, Annette, Steigler, Allison, Kennedy, Angel, Bulsara, Max, Kearvell, Rachel, Joseph, David J., Denham, James W.

Association between treatment planning and delivery factors and disease progression in prostate cancer radiotherapy: Results from the TROG 03.04 RADAR trial

- Marcello, Marco, Ebert, Martin, Haworth, Annette, Steigler, Allison, Kennedy, Angel, Joseph, David, Denham, James

Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancer

- D'Amico, Anthony V., Chen, Ming-Hui, Crook, Juanita, Armstrong, John G., Malone, Shawn, Steigler, Allison, Dunne, Mary, Kantoff, Phillip W., Denham, James W.

External validation of a predictive model of urethral strictures for prostate patients treated with HDR Brachytherapy boost

- Panettieri, Vanessa, Rancati, Tiiziana, Onjukka, Eva, Ebert, Martin A., Joseph, David J., Denham, James W., Steigler, Allison, Millar, Jeremy L.

High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient–data Network Meta-analysis from the MARCAP Consortium

- Kishan, Amar U., Wang, Xiaoyan, De Reijke, Theo, Neven, Anouk, Steigler, Allison, Denham, James W., Joseph, David, Nabid, Abdenour, Carrier, Nathalie, Souhami, Luis, Sydes, Matt R., Dearnaley, David P., Sun, Yilun, Syndikus, Isabel, Tree, AC, Incrocci, L, Heemsbergen, WD, Pos, FJ, Zapatero, A, Efstathiou, JA, Guerrero, A, Alvarez, A, San-Segundo, CG, Romero, Tahmineh, Maldonado, X, Xiang, M, Rettig, MB, Reiter, RE, Zaorsky, NG, Ong, WL, Dess, RT, Steinberg, ML, Nickols, NG, Roy, S, Michalski, Jeff M., Garcia, JA, Spratt, DE, MARCAP Consortium,, Ma, Ting Martin, Feng, Felix Y., Sandler, Howard M., Bolla, Michel, Maingon, Philippe

Increased dose to organs in urinary tract associates with measures of genitourinary toxicity in pooled voxel-based analysis of 3 randomized phase III trials

- Marcello, Marco, Denham, James W., Kennedy, Angel, Haworth, Annette, Steigler, Allison, Greer, Peter B., Holloway, Lois C., Dowling, Jason A., Jameson, Michael G., Roach, Dale, Joseph, David J., Gulliford, Sarah L., Dearnaley, David P., Sydes, Matthew R., Hall, Emma, Ebert, Martin A.

Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial

- Capp, Anne, Inostroza-Ponta, Mario, Atkinson, Chris, North, John, Poulsen, Michael, Spry, Nigel A., Tai, Keen-Hun, Wynne, Chris, Duchesne, Gillian, Steigler, Allison, Denham, James W., Bill, Dana, Moscato, Pablo, Lai, Chi, Christie, David, Lamb, David, Turner, Sandra, Joseph, David, Matthews, John

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)

- Ma, Ting Martin, Chu, Fang-I, Bolla, Michel, de Reijke, Theo M., Maingon, Philippe, Neven, Anouk, Denham, James, Steigler, Allison, Joseph, David J., Nabid, Abdenour, Souhami, Luis, Carrier, Nathalie, Sandler, Howard, Incrocci, Luca, Heemsbergen, Wilma, Pos, Floris J., Sydes, Matthew R., Dearnaley, David P., Tree, Alison C., Syndikus, Isabel, Hall, Emma, Cruickshank, Clare, Malone, Shawn, Feng, Felix Y., Roy, Soumyajit, Sun, Yilun, Zaorsky, Nicholas G., Nickols, Nicholas G., Reiter, Robert E., Rettig, Matthew B., Steinberg, Michael L., Reddy, Vishruth K., Xiang, Michael, Romero, Tahmineh, Efstathiou, Jason A., Spratt, Daniel E., Kishan, Amar U., Meta-analysis of Randomized trials in Cancer of the Prostate MARCAP Consortium investigators,, Jones, Christopher U., Roach, Mack, Rosenthal, Seth A., Pisansky, Thomas, Michalski, Jeff M.

Long-term quality-of-life outcomes following prostate radiotherapy with or without high-dose-rate brachytherapy boost: post-hoc analysis of TROG 03.04 RADAR

- Ong, Wee Loon, Nikitas, John, Nickols, Nicholas G., Chang, Albert, Zaorsky, Nicholas G., Spratt, Daniel E., Romero, Tahmineh, Kishan, Amar U., Joseph, David, Steigler, Allison, Millar, Jeremy, Valle, Luca, Steinberg, Michael L., Martin, Ting, Reiter, Robert E., Rettig, Matthew B.

Measuring personal and functional changes in prostate cancer survivors: development and validation of the FADE: data from the TROG 03.04 RADAR trial

- Bitsika, Vicki, Sharpley, Christopher F., Christie, David R. H., Bradford, Rosemary, Steigler, Allison, Denham, James W.

Measuring time to biochemical failure in the Trog 96.01 trial: when should the clock start ticking?

- Denham, James W., Steigler, Allison, Gleeson, Paul S., D'Este, Catherine, Kumar, Mahesh, Lamb, David S., Joseph, David, Spry, Nigel A., Tai, Keen-Hun, Atkinson, Chris, Turner, Sandra, Greer, Peter B.

Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial

- Sridharan, Swetha, Steigler, Allison, Attia, John, Holliday, Elizabeth G., Denham, James W., Spry, Nigel A., Joseph, David, Lamb, David S., Matthews, John H., Atkinson, Chris, Tai, Keen-Hun, Duchesne, Gillian, Christie, David

Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer

- Denham, James W., Steigler, Allison, Wynne, Chris, Lamb, David S., Tai, Keen-Hun, Joseph, David, Matthews, John, Atkinson, Chris, Spry, Nigel A., Turner, Sandra, North, John, Christie, David

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial

- Delahunt, Brett, Murray, Judith D., Steigler, Allison, Atkinson, Chris, Christie, David, Duchesne, Gillian, Egevad, Lars, Joseph, David, Matthews, John, Oldmeadow, Christopher, Samaratunga, Hemamali, Spry, Nigel A., Srigley, John R., Hondermarck, Hubert, Denham, James W.

Picking the optimal duration of hormonal therapy in men with high-risk and locally advanced prostate cancer treated with radiotherapy

- Denham, James W., Steigler, Allison